CXCL9 as a Prognostic Inflammatory Marker in Early-Stage Lung Adenocarcinoma Patients

Background: This study was performed to evaluate the value of inflammatory biomarkers in predicting the prognosis of early-stage (stage IA-IIB) lung adenocarcinoma. Methods: Ten inflammatory biomarkers were tested with a Luminex bead-based assay in early-stage lung adenocarcinoma patients who underw...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Oncol
Main Authors: Zhang, Yanwei, Sun, Beibei, Hu, Minjuan, Lou, Yuqing, Lu, Jun, Zhang, Xueyan, Wang, Huimin, Qian, Jialin, Chu, Tianqing, Han, Baohui
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2020
Assuntos:
Oncology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7347039/
https://ncbi.nlm.nih.gov/pubmed/32714866
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.01049
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados